As the recognition of mitochondrial dysfunction in alcoholic
liver disease has grown, there is an expanding list of pharmacological agents being tested in experimental animal models of alcohol toxicity. For example, the aldehyde dehydrogenase 2 activator, Alda-1, reverses alcohol-induced steatosis and attenuates
apoptosis